In the last trading session, 12,657,190 Conformis, Inc. (NASDAQ:CFMS) shares changed hands as the company’s beta touched 1.2. With the company’s per share price at $1.25 changed hands at -$0.09 or -0.07% during last session, the market valuation stood at $228.1 Million. CFMS’s last price was a discount, traded about -19.2% off its 52-week high of $1.49. The share price had its 52-week low at $0.602, which suggests the last value was 51.84% up since then. When we look at Conformis, Inc.’s average trading volume, we note the 10-day average is 5.94 Million shares, with the 3-month average coming to 2.52 Million.
Analysts gave the Conformis, Inc. (CFMS) stock a consensus recommendation rating of Overweight, calculated at a mean rating of 2. If we narrow down to specifics, the data shows that 1 out of 4 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, none recommended CFMS as a Hold, 3 felt it is a Buy and none rated the stock as Underweight. Conformis, Inc.’s EPS for the current quarter is expected to be $0.04.
Conformis, Inc. (NASDAQ:CFMS) trade information
Although CFMS has turned red as seen at the end of in last trading. With action -6.72%, the performance over the past five days has been green. The jump to weekly highs of $1.345 on Thursday, Jun 17 added 7.06% to the stock’s daily price. The company’s shares are showing year-to-date upside of 0.89%, with the 5-day performance at 0.24% in the green. However, in the 30-day time frame, Conformis, Inc. (NASDAQ:CFMS) is 0.51% up. Looking at the short shares, we see there were 1.93 Million shares sold at short interest cover period of 0.77 days.
The consensus price target for the stock as assigned by Wall Street analysts is $2.33, meaning bulls need an upside of 86.4% from its current market value. According to analyst projections, CFMS’s forecast low is $2 with $3 as the target high. To hit the forecast high, the stock’s price needs a +140% upsurge from its current level, while the stock would need to tank 60% for it to hit the projected low.
Conformis, Inc. (CFMS) estimates and forecasts
Data shows that the Conformis, Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot +93.35% over the past 6 months, a 47.06% in annual growth rate that is considerably higher than the industry average of 19.2%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2021 revenue estimates. The rating firms predict current quarter revenue for Conformis, Inc. will rise +233.3%, while the growth in revenue is estimated to hit 22.2% for the next quarter. Year-over-year growth is forecast to reach 22.9% up from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of $33Million. 4 analysts are of the opinion that Conformis, Inc.’s revenue for the quarter ending September 01, 2021 will be $17.21 Million. The company’s revenue for the corresponding quarter a year ago was $19.47 Million. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 69.5%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 33.5%. The 2021 estimates are for Conformis, Inc. earnings to increase by 23.7%, but the outlook for the next 5-year period is at -14.58% per year.
Conformis, Inc. (NASDAQ:CFMS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 4.3% of Conformis, Inc. shares while 50.66% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 52.94%. There are 89 institutions holding the Conformis, Inc. stock share, with Wasatch Advisors Inc the top institutional holder. As of Mar 30, 2021, the company held 9.71% of the shares, roughly 17.72 Million CFMS shares worth $17.54 Million.
Consonance Capital Management LP holds the second largest percentage of outstanding shares, with 7.12% or 13Million shares worth $12.87 Million as of Mar 30, 2021.
Among Mutual Funds, the top two as of Mar 30, 2021 were Wasatch Ultra Growth Fund and Vanguard Total Stock Market Index Fund. With 13974921 shares estimated at $13.84 Million under it, the former controlled 7.66% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 2.44% of the shares, roughly 4.45 Million shares worth around $4.41 Million.